Article Text

QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.